Xenetic Biosciences, Inc. (XBIO)

Xenetic Biosciences Revenue

Xenetic Biosciences had revenue of $589.90K in the quarter ending June 30, 2025, a decrease of -18.79%. This brings the company's revenue in the last twelve months to $2.45M, down -2.94% year-over-year. In the year 2024, Xenetic Biosciences had annual revenue of $2.50M, down -1.56%.

• Revenue (ttm): $2.45M
• Revenue Growth: -2.94%
• P/S Ratio: 1.88
• Revenue / Employee: $1,223,111
• Employees: 2
• Market Cap: 4.55M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.50M	-39.70K	-1.56%
Dec 31, 2023	2.54M	833.06K	48.80%
Dec 31, 2022	1.71M	546.23K	47.06%
Dec 31, 2021	1.16M	723.75K	165.64%
Dec 31, 2020	436.94K	419.88K	2,460.31%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.